leadf
logo-loader
viewHansen Medical

Hansen Medical shares burgeon by 50% after FDA green light

Euphoria was investors' reaction to news that Hansen Medical was granted clearance for its Robotic Catheter eKit from U.S. authorities and the company's shares advanced 50%.

Catheter.jpg
Robotic Catheter eKits get FDA clearance
Euphoria was investors' reaction to news that Hansen Medical (NASDAQ:HNSN) was granted clearance for its Robotic Catheter eKit from US authorities and the company's shares advanced 50%.
 
Although widely touted as ripe for clearance, the news that Hansen Medical's Magellan Robotic Catheter eKit had received the nod from the US Food and Drug Administration came as some relief.
 
Shares raced up by as much as 50.6% to US$4.82 earlier, having traded at around US$2 in the last week of January. The price was last seen up 29%, or 92 cents at USD4.12.
 
The eKits allow doctors to control third party microcatheters robotically through current Megellan Robotic Catheter 6Fr architecture. The goal of the kits is to help reduce exposure time to radiation and overall procedure time.
 

Quick facts: Hansen Medical

Price: - -

NASDAQ:HNSN
Market: NASDAQ
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Thunderbird Entertainment releases fall slate of shows on streaming services...

Thunderbird Entertainment Group (CVE: TBRD-OTC: THBRF) CEO Jennifer Twiner McCarron joined Steve Darling from Proactive Vancouver with news the company has released their fall slate of shows. The company will have 7 new and returning show including animated, scripted, and factual. Twiner...

10 hours, 18 minutes ago

2 min read